To further enhance proliferation and anti-tumour activity of CAR-NK cells, the authors coupled iMC activation with ectopic IL-15, and for safety reasons, they incorporated an orthogonal rapamycin-regulated Caspase-9 (iRC9) safety switch to eliminate the CAR-NKs if needed [210]. The gene discussed is IL15; the disease is neoplasm.